AXNX | Axonics, Inc. | [NASD]
Index- P/E- EPS (ttm)-0.99 Insider Own0.70% Shs Outstand48.58M Perf Week-3.56%
Market Cap2.50B Forward P/E- EPS next Y-0.04 Insider Trans-41.76% Shs Float47.10M Perf Month-14.38%
Income-46.30M PEG- EPS next Q-0.12 Inst Own103.26% Short Float / Ratio8.83% / 6.50 Perf Quarter-17.56%
Sales295.90M P/S8.45 EPS this Y31.20% Inst Trans3.08% Short Interest4.16M Perf Half Y-25.28%
Book/sh11.87 P/B4.09 EPS next Y89.50% ROA-7.50% Target Price78.58 Perf Year-2.08%
Cash/sh6.93 P/C7.01 EPS next 5Y- ROE-8.70% 52W Range46.57 - 79.92 Perf YTD-22.37%
Dividend- P/FCF281.10 EPS past 5Y-12.40% ROI-10.90% 52W High-39.26% Beta0.40
Dividend %- Quick Ratio6.10 Sales past 5Y363.40% Gross Margin73.30% 52W Low4.23% ATR2.22
Employees610 Current Ratio7.10 Sales Q/Q46.10% Oper. Margin-18.80% RSI (14)33.61 Volatility3.67% 4.34%
OptionableYes Debt/Eq0.00 EPS Q/Q62.10% Profit Margin-15.60% Rel Volume0.83 Prev Close49.65
ShortableYes LT Debt/Eq0.00 EarningsMay 01 AMC Payout- Avg Volume640.12K Price48.54
Recom2.00 SMA20-8.93% SMA50-12.59% SMA200-22.79% Volume532,148 Change-2.24%
Date Action Analyst Rating Change Price Target Change
May-23-23Initiated CL King Buy $75
Apr-14-23Initiated Mizuho Buy $75
Mar-24-23Upgrade Needham Hold → Buy $71
Oct-21-22Initiated RBC Capital Mkts Outperform $85
Oct-12-22Initiated Jefferies Hold $75
Oct-10-22Downgrade Needham Buy → Hold
Apr-06-22Initiated Wolfe Research Outperform $69
Mar-02-22Resumed BofA Securities Buy $70
Jul-12-21Initiated Barclays Overweight $74
Jun-28-21Reiterated Needham Buy $72 → $78
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:01PM
06:00AM Loading…
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
10:00AM Loading…
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
06:00AM Loading…
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Aug-17-22 06:00AM
Aug-08-22 12:00PM
Aug-05-22 04:34PM
Aug-04-22 09:40AM
Aug-02-22 11:13PM
04:11PM
Aug-01-22 05:15PM
04:01PM
Jul-19-22 09:40AM
Jul-15-22 07:24AM
Jul-11-22 06:00AM
Jun-24-22 09:40AM
Jun-15-22 08:18AM
May-31-22 06:00AM
May-05-22 05:45PM
04:01PM
May-02-22 08:19AM
Apr-28-22 03:02PM
Apr-26-22 06:00AM
Apr-19-22 06:00AM
Apr-14-22 04:01PM
Apr-04-22 06:00AM
Mar-23-22 09:28AM
Mar-07-22 04:01PM
Feb-24-22 06:20PM
04:01PM
Feb-23-22 05:25PM
Feb-17-22 03:02PM
Feb-14-22 05:15PM
Feb-05-22 06:48AM
Feb-03-22 06:00AM
Feb-02-22 01:38PM
Feb-01-22 06:00AM
Jan-25-22 06:00AM
Jan-07-22 08:13AM
Jan-06-22 06:00AM
Dec-11-21 05:38AM
Nov-30-21 06:00AM
Nov-17-21 06:00AM
05:01AM
Nov-09-21 12:14PM
Nov-08-21 06:00AM
Nov-07-21 06:57AM
Nov-05-21 10:30AM
Nov-04-21 05:55PM
04:01PM
Oct-26-21 06:00AM
Oct-25-21 04:10PM
Oct-07-21 07:00AM
Sep-23-21 09:59AM
Sep-22-21 06:08PM
Sep-13-21 05:19PM
Sep-02-21 06:12AM
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dearen Danny L.President & CFOApr 21Option Exercise14.1913,208187,42237,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 21Sale60.2120,0001,204,13717,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 20Option Exercise14.192,00128,39425,994Apr 24 08:35 PM
Dearen Danny L.President & CFOApr 20Sale60.012,001120,07323,993Apr 24 08:35 PM
Dearen Danny L.President & CFOMar 31Option Exercise16.0015,000240,03138,993Apr 04 08:24 PM
Dearen Danny L.President & CFOMar 31Sale55.2715,000829,10323,993Apr 04 08:24 PM
Sama RindaChief Operating OfficerFeb 21Sale56.2719,9291,121,41555,854Feb 23 08:19 PM
Sama RindaChief Operating OfficerFeb 21Sale56.533,392191,750608Feb 23 08:19 PM
COHEN RAYMOND WChief Executive OfficerFeb 01Sale60.938,117494,578160,596Feb 02 08:06 PM
Sama RindaChief Operating OfficerFeb 01Sale60.935,075309,22575,783Feb 02 08:07 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerFeb 01Sale60.933,979242,44565,302Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerFeb 01Sale60.933,705225,75050,834Feb 02 08:07 PM
Dearen Danny L.President & CFOFeb 01Sale60.933,246197,78223,993Feb 02 08:06 PM
Noblett KarenChief Medical OfficerFeb 01Sale60.9393156,72742,215Feb 02 08:06 PM
Dearen Danny L.President & CFOJan 31Option Exercise0.0025,250037,750Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerJan 31Option Exercise0.0016,500060,773Feb 02 08:07 PM
Sama RindaChief Operating OfficerJan 31Option Exercise0.0030,875094,283Feb 02 08:07 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31Option Exercise0.0022,125076,851Feb 02 08:06 PM
Noblett KarenChief Medical OfficerJan 31Option Exercise0.0010,250046,849Feb 02 08:06 PM
COHEN RAYMOND WChief Executive OfficerJan 31Option Exercise0.0061,9680191,617Feb 02 08:06 PM
COHEN RAYMOND WChief Executive OfficerJan 31Sale61.1522,9041,400,595168,713Feb 02 08:06 PM
Sama RindaChief Operating OfficerJan 31Sale61.1513,425820,93280,858Feb 02 08:07 PM
Dearen Danny L.President & CFOJan 31Sale61.1610,511642,82227,239Feb 02 08:06 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31Sale61.147,570462,85469,281Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerJan 31Sale61.156,234381,23554,539Feb 02 08:07 PM
Noblett KarenChief Medical OfficerJan 31Sale61.153,703226,43743,146Feb 02 08:06 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 17Option Exercise17.4830,215528,05060,976Jan 19 08:07 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 17Sale67.3430,2152,034,53145,976Jan 19 08:07 PM
Ford Alfred J JrChief Commercial OfficerJan 13Option Exercise13.5236,015486,81772,788Jan 18 08:03 PM
COHEN RAYMOND WChief Executive OfficerJan 13Sale65.9440,7362,686,001108,899Jan 18 08:04 PM
Ford Alfred J JrChief Commercial OfficerJan 13Sale66.4036,0152,391,41536,773Jan 18 08:03 PM
Lopez EstebanDirectorDec 13Sale67.422,000134,8403,600Dec 15 08:12 PM
Dearen Danny L.See RemarksSep 13Sale75.6065649,5947,500Sep 15 08:03 PM
Noblett KarenChief Medical OfficerSep 12Option Exercise19.1932,483623,33564,082Sep 20 08:23 PM
Noblett KarenChief Medical OfficerSep 12Sale78.1632,4832,538,80031,599Sep 20 08:23 PM
Woock JohnChief Marketing OfficerSep 08Option Exercise1.527,50011,42749,776Sep 12 08:03 PM
Woock JohnChief Marketing OfficerSep 08Sale75.007,500562,52445,976Sep 12 08:03 PM
Noblett KarenChief Medical OfficerSep 07Sale71.5310,454747,79431,599Sep 09 08:06 PM
Woock JohnChief Marketing OfficerAug 25Sale72.957,500547,11345,976Aug 26 07:25 PM
Dearen Danny L.See RemarksAug 11Option Exercise7.9937,502299,69158,156Aug 15 08:34 PM
Dearen Danny L.See RemarksAug 11Sale70.8950,0003,544,5238,156Aug 15 08:34 PM
Sama RindaChief Operating OfficerAug 10Option Exercise17.0433,850576,87288,508Aug 12 07:48 PM
Woock JohnChief Marketing OfficerAug 10Option Exercise1.637,50012,22568,476Aug 12 07:49 PM
Sama RindaChief Operating OfficerAug 10Sale69.5633,8502,354,65054,658Aug 12 07:48 PM
Woock JohnChief Marketing OfficerAug 10Sale69.7115,0001,045,64753,476Aug 12 07:49 PM
COHEN RAYMOND WChief Executive OfficerAug 08Sale70.4444,0003,099,326149,635Aug 10 07:29 PM
Kiernan Jane EDirectorJul 05Sale60.005,250315,00014,761Jul 07 08:20 PM